Rare Disease Day is a pivotal time to raise awareness and support for those living with rare conditions such as Neurofibromatosis type 2-related Schwannomatosis (NF2-SWN). Read about the research that NF2BioSolutions funded PhD student Reygn Done is working on…
Join us on Saturday 15 March at Friends’ Meeting House in Manchester City Centre for an enlightening day dedicated to brain health. Discover more about brain diseases such as stroke, dementia, brain tumours and Parkinson’s disease including a special screening of The Parkinson’s Project. The event is free to attend and open to the public – everyone is welcome.
Lindonlight Collective has awarded $1.97 million to our Chair of Translational Neuro-Oncology Professor Petra Hamerlik for her pioneering work on pediatric low-grade gliomas.
It is with enormous sadness that we announce the death of Professor Pippa Tyrrell, emeritus Professor of Stroke Medicine at the University of Manchester and retired consultant in stroke medicine at Salford Royal
Translation Manchester has announced the Confidence for Translation (C4T) awardees. The call was extremely competitive and we’re proud to celebrate our colleagues at the Centre whose projects were awarded.
Dr Sasha Philbert has been awarded a prestigious 4-year Alzheimer’s Society Fellowship. Dr Philbert’s research aims to improve the diagnostic accuracy of vascular dementia by distinguishing it from early-stage Alzheimer’s disease.
Researchers at Greater Manchester Mental Health NHS Foundation Trust and the Northern Care Alliance, working with colleagues in the Geoffrey Jefferson Brain Research Centre and international collaborators in Spain and Italy have found that people with both cognitive impairment and chronic kidney disease (CKD) had worse health outcomes than people with CKD alone.
It is with great regret that we in the Geoffrey Jefferson Brain Research Centre join others in acknowledging the recent death of Professor Tipu Aziz.
The clinical investigation study was conducted at Salford Royal Hospital, part of Northern Care Alliance NHS Foundation Trust in Manchester, UK. The study was led by Chief Clinical Investigator Dr David Coope, a neurosurgeon at the Manchester Centre for Clinical Neuroscience and Brain Tumours Theme Lead at the Geoffrey Jefferson Brain Research Centre, and Chief Scientific Investigator Kostas Kostarelos, PhD, Professor of Nanomedicine at The University of Manchester, the Catalan Institute of Nanoscience & Nanotechnology, and Co-Founder of INBRAIN.
Our centre was proud to sponsor and attended an event in Manchester that bought together brain tumour experts from across the UK to discuss innovative ways to improve brain tumour diagnosis nationally.
Geoffrey Jefferson Brain Research Centre
Clinical Sciences Building
Northern Care Alliance
NHS Foundation Trust
Salford
M6 8FJ
Email: GJBRC@manchester.ac.uk
Recent Comments